• Greeting
• Corporate Philosophy
• Corporate Profile
• Board of Directors
• Organizational Chart
• History
• Locations
• Seikagaku; Quick Overview

History

1947

Kosei Suisan K.K. established in Minato-ku, Tokyo.
Kurihama Plant opens in Kanagawa.

1950

Industrial production of chondroitin sulfate as a pharmaceutical begins.

1952

Head Office relocated to Chuo-ku, Tokyo.

1953

Official name of company changed to K.K. Seikagaku Kenkyusho.

1960

Tokyo Research Institute opens in Shinjuku-ku, Tokyo.
Development and marketing of research biochemicals begins.

1962

Official name of company changed to Seikagaku Corporation.

1968

Tokyo Research Institute relocated to Higashiyamato-shi, Tokyo.

1975

Takahagi Plant opens in Ibaraki.

1981

World's first endotoxin colorimetry reagent developed and manufactured.

1987

Marketing begins for hyaluronic acid formulations ARTZ^® and OPEGAN^®.

1989

Company shares registered with the Japan Securities Dealers Association.

1992

Overseas marketing of ARTZ^® begins (Sweden).

1993

New production line for ARTZ Dispo^® completed, and marketing of the product begins.

1997

Acquisition of Associates of Cape Cod, Inc. (U.S.A.)

1998

QA certification [ISO 9001/EN46001 (now ISO 13485)] obtained.

2000

Name of Tokyo Research Institute changed to Central Research Laboratories.

2001

Marketing begins for hyaluronic acid formulation SUPARTZ^® in U.S.A.

2004

Listing moved to the Tokyo Stock Exchange, Second Section.

2005

Listing moved to the Tokyo Stock Exchange, First Section.
Head Office relocated to Chiyoda-ku, Tokyo.

2007

Marketing begins for a hyaluronic acid medical device MucoUp^®.
Seikagaku Biobusiness Corporation established.